The RNA editing landscape in acute myeloid leukemia reveals associations with disease mutations and clinical outcome
Open Access
- 17 November 2022
- Vol. 25 (12) , 105622
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Cambridge Institute for Medical Research, University of Cambridge (100140/Z/12/Z)
- Wellcome Trust (203151/Z/16/Z)
- European Research Council
- European Research Council (647685)
- NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
- Medical Research Council (MR-R009708-1)
- National Institute for Health and Care Research (205254/Z/16/Z)
- Cancer Research UK (C18680/A25508, C67279/A27957)
This publication has 55 references indexed in Scilit:
- GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq dataGenome Biology, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- The accessible chromatin landscape of the human genomeNature, 2012
- DNase I sensitivity QTLs are a major determinant of human expression variationNature, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- DARNED: a DAtabase of RNa EDiting in humansBioinformatics, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003